Mingyue F. Zheng
State Key Laboratory Of Drug Research
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Targeting the FOXP3-T-bet interaction to restore Treg stability in IFN-γ-driven autoimmunity.
Journal: Cellular & molecular immunology
Published: February 01, 2026
Design, Synthesis and Antitumor Activity Evaluation in Vitro of Novel 1,6-Naphthyridine Derivatives.
Design, Synthesis and Antitumor Activity Evaluation in Vitro of Novel 1,6-Naphthyridine Derivatives.
Journal: Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Published: January 30, 2026
AI-driven breakthroughs in ion channel drug discovery: the future is now.
Journal: Acta pharmacologica Sinica
Published: November 03, 2025
Atomic-level protein-ligand recognition with PBCNet2.0 for probe discovery.
Journal: Nature chemical biology
Published: September 23, 2025
Multimodal interpretable deep learning for transcriptome-informed precision oncology and drug mechanism analysis.
Journal: NPJ digital medicine
Published: September 07, 2025
Deep residual learning for molecular force fields.
Journal: Nature communications
Published: August 28, 2025
GlycanInsight: an open platform for carbohydrate-binding pocket prediction and characterization.
Journal: Chemical science
Published: March 25, 2025
Advancing active compound discovery for novel drug targets: insights from AI-driven approaches.
Journal: Acta pharmacologica Sinica
Published: February 17, 2025
Discovery and characterization of a novel HIF-2α agonist for the treatment of CKD-related renal anemia.
Journal: Acta pharmacologica Sinica
Published: December 19, 2024
Targeting STING oligomerization with licochalcone D ameliorates STING-driven inflammatory diseases.
Journal: Science China. Life sciences
Published: April 08, 2024
Fine-tuning large language models for chemical text mining.
Journal: Chemical science
Published: February 06, 2024
Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer.
Journal: Nature cancer
Published: February 01, 2024
Last Updated: 09/26/2026